Signaling via IRAG is essential for NO/cGMP-dependent inhibition of platelet activation

Author： Schinner Elisabeth   Salb Katharina   Schlossmann Jens  

Publisher： Informa Healthcare

ISSN： 1369-1635

Source： Platelets, Vol.22, Iss.3, 2011-05, pp. : 217-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

INVOLVEMENT OF CYCLIC GMP IN THE MODE OF ACTION OF A NEW ANTITHROMBOTIC AGENT PCA-4230; INHIBITION OF THE PLATELET CYCLIC GMP DEPENDENT PHOSPHODIESTERASE

By Catalan R.E.   Martinez A.M.   Aragones M.D.   Lombardia M.  

Thrombosis Research, Vol. 87, Iss. 6, 1997-09 ,pp. : 547-557

Elsevier

Access to resources Recommend Favorite

Ghrelin stimulates proliferation of human osteoblastic TE85 cells via NO/cGMP signaling pathway

By Wang Deng-Hu  

Endocrine Journal, Vol. 35, Iss. 1, 2009-02 ,pp. : 112-117

Humana Press, Inc

Access to resources Recommend Favorite

Endothelial Dysfunction, Impaired Endogenous Platelet Inhibition and Platelet Activation in Diabetes and Atherosclerosis

By  

Current Vascular Pharmacology, Vol. 6, Iss. 1, 2008-01 ,pp. : 52-60

Bentham Science Publishers

Access to resources Recommend Favorite

cGMP-Dependent Protein Kinase in Regulation of the Pulmonary Circulation

By  

Current Respiratory Medicine Reviews, Vol. 2, Iss. 4, 2006-11 ,pp. : 373-381

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of cGMP-dependent Protein Kinase in Human Atrium

By Mishra M.   Wagner M.B.   Wang Y-g.   Joyner R.W.   Kumar R.  

Journal of Molecular and Cellular Cardiology, Vol. 33, Iss. 8, 2001-08 ,pp. : 1467-1476

Academic Press

Access to resources Recommend Favorite